Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fidaxomicin in SOT Recipients with CDI
NCT02464306Phase 4Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of fidaxomicin in Clostridioides difficile infection (CDI), sponsored by University of Colorado Denver. Planned start Jun 2018; status: withdrawn.
02
Drugs
fidaxomicin
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02464306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464306.